Skip to main content
Hit enter to search or ESC to close
Close Search
Bell Direct
search
Menu
  • What You Get
  • Fees
  • Products
  • Investor Solutions
    • Bell Direct Advantage
    • SMSF
      • Setup your SMSF
      • Switch your SMSF
      • Existing Clients
    • Settlement Solutions
      • Settlement Options
      • Macquarie Cash Management Account
      • Macquarie CMA FAQs
    • Experienced investors
  • Insights
    • Overview
    • BDTV Videos
    • Articles
    • Podcasts
    • Reporting Season
  • FAQ
  • Login
  • Join
  •   __PRESENT__PRESENT __PRESENT__PRESENT__PRESENT __PRESENT __PRESENT __PRESENT __PRESENT __PRESENT__PRESENT__PRESENT__PRESENT__PRESENT
  • search
  __PRESENT__PRESENT __PRESENT__PRESENT__PRESENT __PRESENT __PRESENT __PRESENT __PRESENT __PRESENT__PRESENT__PRESENT__PRESENT__PRESENT
  • What You Get
  • Fees
  • Products
  • Investor Solutions
    • Bell Direct Advantage
    • SMSF
      • Setup your SMSF
      • Switch your SMSF
      • Existing Clients
    • Settlement Solutions
      • Settlement Options
      • Macquarie Cash Management Account
      • Macquarie CMA FAQs
    • Experienced investors
  • Insights
    • Overview
    • BDTV Videos
    • Articles
    • Podcasts
    • Reporting Season
  • FAQ
  • Login
  • Join

Results For "ERA"

2567 results found

Earnings Edge Episode 16: Daily Recap and Deep Dive into Mineral Resources (ASX:MIN)

The Commercial Era of Space Has Arrived – ASX:MOON Page

From the helm: Solstice Minerals (ASX:SLS), Managing Director and CEO Nick Castleden

Between the Bells

From the helm: Solstice Minerals (ASX:SLS), Managing Director and CEO Nick Castleden

From the helm: Amplia Therapeutics (ASX:ATX), CEO & MD, Christopher Burns & Bell Potter Analyst, Thomas Wakim.

Between the Bells

From the helm: Amplia Therapeutics (ASX:ATX), CEO & MD, Christopher Burns & Bell Potter Analyst, Thomas Wakim.

From the helm: Alterity Therapeutics (ASX:ATH), CEO, David Stamler.

Between the Bells

From the helm: Alterity Therapeutics (ASX:ATH), CEO, David Stamler.

CY25: gold glitters, AI accelerates and defence dominates. Are markets set for one more Santa rally? Blog Post

Bellcast Cover Image

From the helm: Argenica Therapeutics (ASX:AGN), Dr. Liz Dallimore, CEO & MD

From the helm: Argenica Therapeutics (ASX:AGN), Dr. Liz Dallimore, CEO & MD

From the helm: Cynata Therapeutics (ASX:CYP), Kilian Kelly, CEO

Bellcast Cover Image

From the helm: Cynata Therapeutics (ASX:CYP), Kilian Kelly, CEO

Bellcast Cover Image

From the helm: Linq Minerals, Executive Chairman, Clive Donner

From the helm: Linq Minerals, Executive Chairman, Clive Donner

Weekly Wrap 4 April: How markets reacted to Liberation Day Blog Post

IPO – Minerals 260 Page

From the helm: Opthea Ltd (ASX:OPT) Chief Executive Officer, Fred Guerard

  • 1
  • 2
  • 3
  • …
  • 143
  • Next
Bell Direct
  • Login
  • Join
  • About us
  • Compare us
  • Contact
  • FAQ
  • Media enquiries

WeMoney 2026
Best for Market Research Insights

WeMoney - Winner 2025 - Best for market research insights.

WeMoney 2025
Best for Market Research Insights

WeMoney - Winner 2026 - Finalist for IPO Access.

WeMoney 2026
Finalist for IPO Access
Investment Trends Ranked 1st

Highest Overall
Client Satisfaction
2013-2023
© 2026 Bell Direct
  • Terms & Conditions
  • Privacy Policy
  • Financial Services Guide
The Bell Direct service is provided by Third Party Platform Pty Limited trading as "Bell Direct" (ABN 74 121 227 905) an Australian Financial Services licensee (AFSL 314341) a Participant of the ASX Limited Group and a Trading Participant of Cboe Australia. Bell Direct does not provide investment advice. You should consider your own financial situation, particular needs and investment objectives before acting on any of the information available on this website.

Bell Direct Mobile App Waitlist

Enter your details to join our mobile app waitlist and receive early access to the Bell Direct App.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.